- A participant proposed developing a “reduced-risk DIY gene-therapy protocol” that would test constructs in vitro on patient-derived biopsy tissues and add quality-control steps to verify off-target RNA/DNA binding before in-vivo use.  
- Discussion of cryonics-oriented gene therapy centered on whether adult humans could be retro-fitted with desiccation/cryo-protective pathways; skepticism was voiced that adult physiology may be incompatible with the required biochemical changes.  
- Selective-breeding vs. direct genetic engineering was debated for creating cryonics-resistant mammals: one side advocated mutagenizing and screening millions of mice in <20 years, the other argued for inserting bacterial trehalose-synthesis genes (otsA/otsB) via viral vectors to accelerate the timeline.  
- A 2000 paper showing adenoviral expression of E. coli trehalose genes enabled human fibroblasts to survive five days in a desiccated, water-free state was surfaced, along with a 2014 follow-up on cell-penetrating peptides that deliver trehalose into mammalian cells with low cytotoxicity.  
- Finland’s 2015 integration of non-invasive maternal blood screening for fetal chromosomal anomalies into public healthcare was highlighted as a way to cut invasive needle biopsies (and their ~1 % miscarriage risk) by more than half.  
- A company health plan offering up to $40 k lifetime fertility benefits—including IVF, gamete/embryo cryopreservation, and cord-blood banking—sparked speculation about possible insurance fraud for general-purpose biobanking or stem-cell access.  
- Meredith L. Patterson’s “Neuro Hacking” village at 32C3 was announced, featuring open-source neurofeedback tools that reportedly cured her insomnia; the session was framed as part of the broader DIY-BCI scene.  
- Hackerspace sustainability models were discussed: replacing membership dues with paid consulting, and organizing as a nonprofit medical-research entity that licenses discoveries to larger biotech firms.